PRA Health Sciences

Supporting Each Phase of Drug Development. Supported by a Global Microsampling Specialist.

Since 2000, PRA Health Sciences (PRAHS) has participated in approximately 4,000 clinical trials worldwide. In addition, the company has participated in the pivotal or supportive trials that led to US Food and Drug Administration (FDA) or international regulatory approval of more than 95 drugs.

In 2021, PRAHS became an ICON plc company, with laboratories in multiple locations to support drug development. The labs offer bioanalytical services with the use of various analytical techniques, which include LC-MS/MS and HRMS. The clinical studies that are performed range from Phase I to Phase IV, and the laboratories also support pre-clinical studies.

A global microsampling specialist is involved in all microsampling projects and the team has (co-)authored over 20 publications regarding microsampling. The team regularly performs method development, validation and bioanalysis studies using microsampling.

Our labs can be of service for all your microsampling projects.